These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation. Yang DH, Lee JJ, Mun YC, Shin HJ, Kim YK, Cho SH, Chung IJ, Seong CM, Kim HJ. Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129 [Abstract] [Full Text] [Related]
9. [Prognosis and chromosomal abnormalities in 79 children with t (8;21) acute myeloid leukemia]. Chen YM, Liu TF, Ruan M, Zou Y, Chen XJ, Guo Y, Wang SC, Zhu XF. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):542-6. PubMed ID: 19968066 [Abstract] [Full Text] [Related]
10. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression. Junghanss C, Waak M, Knopp A, Kleine HD, Kundt G, Leithäuser M, Hilgendorf I, Wolff D, Casper J, Freund M. Neoplasma; 2005 Oct; 52(5):402-10. PubMed ID: 16151585 [Abstract] [Full Text] [Related]
11. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation. Gorin NC, Labopin M, Frassoni F, Milpied N, Attal M, Blaise D, Meloni G, Iori AP, Michallet M, Willemze R, Deconninck E, Harousseau JL, Polge E, Rocha V. J Clin Oncol; 2008 Jul 01; 26(19):3183-8. PubMed ID: 18506024 [Abstract] [Full Text] [Related]
12. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup. Prébet T, Boissel N, Reutenauer S, Thomas X, Delaunay J, Cahn JY, Pigneux A, Quesnel B, Witz F, Thépot S, Ugo V, Terre C, Recher C, Tavernier E, Hunault M, Esterni B, Castaigne S, Guilhot F, Dombret H, Vey N, Acute Leukemia French Association, Groupe Ouest-Est des leucémies et autres maladies du sang (GOELAMS), Core Binding Factor Acute Myeloid Leukemia (CBF AML) intergroup. J Clin Oncol; 2009 Oct 01; 27(28):4747-53. PubMed ID: 19720919 [Abstract] [Full Text] [Related]
13. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G. Ann Hematol; 2006 Jun 01; 85(6):366-73. PubMed ID: 16523310 [Abstract] [Full Text] [Related]
14. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. Gröschel S, Lugthart S, Schlenk RF, Valk PJ, Eiwen K, Goudswaard C, van Putten WJ, Kayser S, Verdonck LF, Lübbert M, Ossenkoppele GJ, Germing U, Schmidt-Wolf I, Schlegelberger B, Krauter J, Ganser A, Döhner H, Löwenberg B, Döhner K, Delwel R. J Clin Oncol; 2010 Apr 20; 28(12):2101-7. PubMed ID: 20308656 [Abstract] [Full Text] [Related]
15. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22). Lai YY, Qiu JY, Jiang B, Lu XJ, Huang XJ, Zhang Y, Liu YR, Shi HL, Lu DP. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct 20; 13(5):733-40. PubMed ID: 16277833 [Abstract] [Full Text] [Related]
16. Long-term outcomes of de novo acute myeloid leukemia in Thai patients. Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V. J Med Assoc Thai; 2009 Sep 20; 92(9):1143-9. PubMed ID: 19772172 [Abstract] [Full Text] [Related]
17. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Schoch C, Kern W, Schnittger S, Büchner T, Hiddemann W, Haferlach T. Haematologica; 2004 Sep 20; 89(9):1082-90. PubMed ID: 15377469 [Abstract] [Full Text] [Related]
18. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. Lugthart S, Gröschel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL, Jan Ossenkoppele G, Vellenga E, van den Berg-de Ruiter E, Schanz U, Verhoef G, Vandenberghe P, Ferrant A, Köhne CH, Pfreundschuh M, Horst HA, Koller E, von Lilienfeld-Toal M, Bentz M, Ganser A, Schlegelberger B, Jotterand M, Krauter J, Pabst T, Theobald M, Schlenk RF, Delwel R, Döhner K, Löwenberg B, Döhner H. J Clin Oncol; 2010 Aug 20; 28(24):3890-8. PubMed ID: 20660833 [Abstract] [Full Text] [Related]
19. [Analysis of 32 cases of acute leukemia with abnormality of chromosome 7]. Lu Y, Jin J, Chen ZM, Lou JY, Xu WL. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec 20; 21(6):596-9. PubMed ID: 15583990 [Abstract] [Full Text] [Related]
20. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11]. Lu Y, Xu W, Chen Z, Lou J, Jin J. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct 20; 25(5):583-5. PubMed ID: 18841578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]